Éloi Gagnon
15PUBLICATIONS
103CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Feb 04, 2026
Integrative genetic and liver transcriptomic analyses identify TRIB1AL as a target for steatotic liver disease.Émilie Gobeil, Jérôme Bourgault, Eloi Gagnon
|Jul 01, 2025
Appraisal of multiple polygenic risk scores to estimate the risk of myocardial infarction and coronary artery lesions.Hasanga D Manikpurage, Jérôme Bourgault, Ursula Houessou
|May 10, 2025
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: a drug-target Mendelian randomization study.Eloi Gagnon, Dipender Gill, Jérôme Bourgault
|Mar 31, 2025
Remnant cholesterol concentrations best explain the cardiovascular benefit of APOC3 genetic inhibition: a drug target Mendelian randomization study.Eloi Gagnon, Dipender Gill, Stephen Burgess
|Mar 07, 2025
Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study.Eloi Gagnon, Dipender Gill, Dominique Chabot
|Feb 03, 2025
Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.Stephen O Brennan, Peter J Kelly, Sarah Gorey
Pageof 3
Frequent Collaborators
9 joint publications
Benoit J Arsenault
7 joint publications
Sébastien Thériault
6 joint publications
Jérôme Bourgault
5 joint publications
Patricia L Mitchell
5 joint publications
Patrick Mathieu
4 joint publications
Yohan Bossé
4 joint publications
André Tchernof
4 joint publications
Émilie Gobeil
4 joint publications
Hasanga D Manikpurage
4 joint publications
Marie-Claude Vohl
